Trulieve: Analysts Expect Beat On Company Full Year Guidance

Trulieve Cannabis (CSE: TRUL) announced that they will be reporting their fourth quarter and year-end financials pre-market on March 23rd. Analysts have a consensus C$65.83 12-month price target on the company, via a total of 14 analysts, with two analysts have strong buy ratings and the other 12 have buy ratings. The street high comes from Stifel-GMP with a C$107 price target, and the lowest target comes from Echelon Wealth with a C$43 price target.

Twelve analysts have revenue estimates for the fourth quarter. The mean between all 12 is U$162.49 million; this number has been revised upwards from U$159.35 million at the start of the year. Stifel-GMP currently has the highest revenue estimate with U$170.87 million, while the lowest comes from PI Financial with a U$153.25 estimate.

For the full year, management has guided for revenues between U$465 – U$485 million, but the average estimate between 14 analysts is currently U$513.59 million. This number has been revised upwards from U$511.55 million at the start of the year. The street high comes from Stifel-GMP with a U$523.95 full-year revenue estimate.

Onto EBITDA estimates, there are currently 12 analysts who have fourth-quarter EBITDA estimates. The mean is currently U$75.56 million, with this number being revised upwards from U$72.46 million at the start of the year. Street high goes to Needham with a U$81.30 million EBITDA estimate and the lowest being PI Financial with a U$68.87 million estimate.

For the full-year management has also provided guidance for EBITDA in the range of U$205 – U$225 million. The current EBITDA means across 13 analysts is U$252.47 million, with that number basically staying flat year-to-date. Needham currently has the highest full-year estimate at U$258.80 million.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

How to Still Find 10-Bagger Gold and Silver Stocks | Don Durrett

First Majestic Silver: Jerritt Canyon Is BACK!

Canada May Finally Be Backing Its Battery Supply Chain | John Passalacqua – First Phosphate

Recommended

Silver47 Pulls High-Grade Gold and Silver Assays from Nevada Vein Network At Kennedy

Canadian Gold Resources Taps Chernin as Interim CEO in Planned Transition

Related News

Trulieve Receives Backlash Online From Alleged Employees Over Handling Of COVID-19

It appears that Trulieve Cannabis (CSE: TRUL) is facing a slight public relations issue currently....

Friday, July 17, 2020, 10:38:30 PM

Trulieve Listed Warrants Subject To Six Month Hold As Of January 1

Trulieve Cannabis Corp (CSE: TRUL) may seen a swath of free trading warrants exercised over...

Thursday, December 17, 2020, 07:44:23 AM

Trulieve Reports Q4 2020 Revenues Of $168.4 Million, Net Income Of $3.0 Million

Trulieve Cannabis (CSE: TRUL) this morning reported its fourth quarter and full year financial results...

Tuesday, March 23, 2021, 07:26:18 AM

Harvest Health Shareholders Approve Transaction With Trulieve Cannabis

It appears that Harvest health (CSE: HARV) and Trulieve Cannabis (CSE: TRUL) are set to...

Thursday, August 12, 2021, 08:08:03 AM

Trulieve Posts Q1 Revenues Of $215.1 Million, Net Income

Trulieve Cannabis (CSE: TRUL) this morning reported its second quarter financial results, healthily beating analyst...

Thursday, August 12, 2021, 07:38:54 AM